Global Stock News

With Cipla turning healthy post Q1 results, analysts increase target price

post featured image

With Cipla turning healthy post Q1 results, analysts increase target price

Our Bureau
Share prices of Cipla gained almost 12 per cent in intra-day deal on Monday, after the pharma major posted strong quarterly results. After hitting a fresh 52-week high of 814.45 in intra-day deal, the stock closed with a gain of 9.20 per cent at 795.65 on the BSE.
Cipla reported a 26.528 per cent y-o-y growth in its Q1 FY21 consolidated profit at 566.04 crore, thanks to strong performance across its geographies. Revenue from operations grew 9 per cent to 4,346.2 crore.
Most analys…

Click here to view the original article.

Share this article

Scroll to Top